Perspective Share Price
AMEX: CATX | Micro Cap | HealthcarePerspective Stock Performance
Perspective Share Price Today
As of 19 November 2026, Perspective Therapeutics, Inc.'s share price is $0.78. The stock opened at $0.86, compared to its previous close of $0.86. During today's trading session, Perspective Therapeutics, Inc.'s share price traded between $0.78 and $0.87, with an average price of $0.82. Over the past 52 weeks, the stock has recorded a high of $6.16 and a low of $0.78. In terms of performance, Perspective Therapeutics, Inc.'s share price has declined by 80.23% over the last six months and is down 66.94% on a year-on-year basis.
Perspective Share Price Chart
Perspective Quarterly Profit & Loss
All figures in USD
Perspective Annual Profit & Loss
All figures in USD
Perspective Balance Sheet
All figures in USD Million
Perspective Cash Flow
All figures in USD Million
Corporate Actions
About Perspective
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Perspective Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.15 | $0.78 | -30.97% |
Oct 2026 | $2.69 | $1.13 | -58.83% |
Sep 2026 | $3.16 | $2.75 | -13.41% |
Aug 2026 | $2.88 | $3.17 | +9.69% |
Jul 2026 | $3.43 | $2.89 | -15.12% |
Jun 2026 | $3.87 | $3.40 | -13.69% |
May 2026 | $3.90 | $3.94 | +1.15% |
Apr 2026 | $4.16 | $3.90 | -6.47% |
Mar 2026 | $5.12 | $4.17 | -22.63% |
Feb 2026 | $4.14 | $5.39 | +42.59% |
Jan 2026 | $2.75 | $3.78 | +37.45% |
Dec 2025 | $2.29 | $2.75 | +16.53% |